Market Tracker

07/28 6:01pm ET

SPDR® S&P Pharmaceuticals ETF (XPH)

During the Trading Day
131.98 +1.73 / +1.33%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
131.87 -0.11 / -0.08%
Volume: 2.8K

Investment Objective

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index. In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.

No recent news for SPDR® S&P Pharmaceuticals ETF.


1 month+3.81% 3 years+34.10%
3 months+5.96% 5 years+29.72%
1 year+38.96% Since inception+19.06%
Data through 07/28/2015

Quote Details

Previous close$130.25
Open day’s range129.32 – 132.05
Net asset value (NAV)130.23 (07/27/2015)
Daily volume55,464
Average volume (3 months)77,852
Data as of 3:59pm ET, 07/28/2015

Peer Comparisonvs. Health ETFs

Performance 5-yr return+29.72%+26.72%
Expense Gross exp ratio0.35%0.47%
Risk 5 year sharpe ratio1.801.74
Net assets$1.1B$2.0B
Average market cap$6.6B$37.5B
Average P/E29.925.5
Dividend / Share--0.21%


XLV Health Care Select Sector SPDR® Fund
VHT Vanguard Health Care Index Fund ETF Shar...
RYH Guggenheim S&P 500® Equal Weight Health...


Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
TTPH Tetraphase Pharmaceuticals Inc3.33%
ANIP ANI Pharmaceuticals Inc3.25%
NKTR Nektar Therapeutics3.20%
HZNP Horizon Pharma PLC3.19%
LCI Lannett Company Inc3.04%
DEPO Depomed Inc3.02%
CEMP Cempra Inc3.00%
PBH Prestige Brands Holdings Inc2.99%
BMY Bristol-Myers Squibb2.97%
AGN Allergan2.96%